Figure 6.

Hepatic A₁R negatively correlates with the advance of MAFLD

(A) Representative images showing H&E staining and A₁R immunohistochemical (IHC) staining of liver tissue from individuals with or without hepatic steatosis (n = 8∼22).

(B) Hepatic steatosis score.

(C) A₁R IHC-positive staining intensity.

(D) Representative images showing H&E staining and A₁R immunofluorescence staining of livers from healthy control or MASH individuals (n = 9).

(E) NAFLD activity score (NAS).

(F) A₁R fluorescence-positive staining intensity. Results are representative of one biological replicate. Data are depicted as mean ± SEM. Student’s unpaired t test; ∗p < 0.05, ∗∗p < 0.01.